Service Line:+86-022-82164980
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:[email protected]
Catalog Number | YR1108 |
---|---|
Product Name | Anti-Human IL12B Recombinant Antibody(Ustekinumab) |
Molecular Name | Ustekinumab |
Alias | Anti-IL12B Recombinant Antibody, Research Grade Ustekinumab |
CAS Number | 815610-63-0 |
Molecular Weight | 148 kDa |
Target | IL12B[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | FuncS, IF, Neut, ELISA, FCM |
Buffer | PBS, pH7.5 |
Background | Ustekinumab, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, targeting both IL-12 and IL-23. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |